BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 29259523)

  • 1. Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities.
    Quijano E; Bahal R; Ricciardi A; Saltzman WM; Glazer PM
    Yale J Biol Med; 2017 Dec; 90(4):583-598. PubMed ID: 29259523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology for delivery of peptide nucleic acids (PNAs).
    Gupta A; Bahal R; Gupta M; Glazer PM; Saltzman WM
    J Control Release; 2016 Oct; 240():302-311. PubMed ID: 26776051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-nucleic acids (PNAs): a tool for the development of gene expression modifiers.
    Gambari R
    Curr Pharm Des; 2001 Nov; 7(17):1839-62. PubMed ID: 11562312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of Peptide Nucleic Acids Using an Argininocalix[4]arene as Vector.
    Finotti A; Gasparello J; Casnati A; Corradini R; Gambari R; Sansone F
    Methods Mol Biol; 2021; 2211():123-143. PubMed ID: 33336275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression.
    Tyler BM; Jansen K; McCormick DJ; Douglas CL; Boules M; Stewart JA; Zhao L; Lacy B; Cusack B; Fauq A; Richelson E
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):7053-8. PubMed ID: 10359837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide nucleic acids as therapeutic agents.
    Nielsen PE
    Curr Opin Struct Biol; 1999 Jun; 9(3):353-7. PubMed ID: 10361091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Nanoparticle-based Delivery of Next Generation Peptide Nucleic Acids.
    Malik S; Asmara B; Moscato Z; Mukker JK; Bahal R
    Curr Pharm Des; 2018; 24(43):5164-5174. PubMed ID: 30657037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide nucleic acid (PNA) and its applications in chemical biology, diagnostics, and therapeutics.
    Saarbach J; Sabale PM; Winssinger N
    Curr Opin Chem Biol; 2019 Oct; 52():112-124. PubMed ID: 31541865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of Naked Peptide Nucleic Acids into Liposomes Leads to Fast and Efficient Delivery.
    Avitabile C; Accardo A; Ringhieri P; Morelli G; Saviano M; Montagner G; Fabbri E; Gallerani E; Gambari R; Romanelli A
    Bioconjug Chem; 2015 Aug; 26(8):1533-41. PubMed ID: 26176882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide nucleic acids: on the road to new gene therapeutic drugs.
    Nielsen PE
    Pharmacol Toxicol; 2000 Jan; 86(1):3-7. PubMed ID: 10720100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the development of peptide nucleic acid as a gene-targeted drug.
    Marin VL; Roy S; Armitage BA
    Expert Opin Biol Ther; 2004 Mar; 4(3):337-48. PubMed ID: 15006728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide nucleic acids with a structurally biased backbone. Updated review and emerging challenges.
    Corradini R; Sforza S; Tedeschi T; Totsingan F; Manicardi A; Marchelli R
    Curr Top Med Chem; 2011; 11(12):1535-54. PubMed ID: 21510833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA silencing for cancer therapy targeted to the tumour microenvironment.
    Cheng CJ; Bahal R; Babar IA; Pincus Z; Barrera F; Liu C; Svoronos A; Braddock DT; Glazer PM; Engelman DM; Saltzman WM; Slack FJ
    Nature; 2015 Feb; 518(7537):107-10. PubMed ID: 25409146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide nucleic acids: versatile tools for gene therapy strategies.
    Dean DA
    Adv Drug Deliv Rev; 2000 Nov; 44(2-3):81-95. PubMed ID: 11072107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(Lactic-co-Glycolic Acid) Nanoparticle Delivery of Peptide Nucleic Acids In Vivo.
    Oyaghire SN; Quijano E; Piotrowski-Daspit AS; Saltzman WM; Glazer PM
    Methods Mol Biol; 2020; 2105():261-281. PubMed ID: 32088877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide Nucleic Acids and Gene Editing: Perspectives on Structure and Repair.
    Economos NG; Oyaghire S; Quijano E; Ricciardi AS; Saltzman WM; Glazer PM
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32046275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs.
    Fabbri E; Brognara E; Borgatti M; Lampronti I; Finotti A; Bianchi N; Sforza S; Tedeschi T; Manicardi A; Marchelli R; Corradini R; Gambari R
    Epigenomics; 2011 Dec; 3(6):733-45. PubMed ID: 22126292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular delivery of peptide nucleic acid (PNA).
    Koppelhus U; Nielsen PE
    Adv Drug Deliv Rev; 2003 Feb; 55(2):267-80. PubMed ID: 12564980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activity and delivery of peptide nucleic acids (PNA)-DNA chimeras for transcription factor decoy (TFD) pharmacotherapy.
    Gambari R
    Curr Med Chem; 2004 May; 11(10):1253-63. PubMed ID: 15134518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular delivery of peptide nucleic acid and organic molecules using zeolite-L nanocrystals.
    Bertucci A; Lülf H; Septiadi D; Manicardi A; Corradini R; De Cola L
    Adv Healthc Mater; 2014 Nov; 3(11):1812-7. PubMed ID: 24789252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.